Fresh research from Switzerland indicates that the diabetes drug Avandia could pose further risks to diabetic patients. Avandia caused media furore last year when it emerged that the drug dramatically increased the risk of heart problems and death amongst diabetics .
The decline of the drug has impacted on company sales of manufacturer GlaxoSmithKline. Now, it appears that the diabetes drug alongside a similar drug of the same class Actos, could increase the risk of bone fracture by almost 50 per cent.

Both drugs are prescribed to regulate blood sugar levels, but it appears that both increase the risk of brittle bones and osteoporosis . Any diabetic being put onto Avandia should therefore, experts say, be thoroughly screened for heart problems and bone-density.
How the news impacts on Avandia remains to be seen.

Get our free newsletters

Stay up to date with the latest news, research and breakthroughs.

You May Also Like

Type 2 diabetes found to be a ‘significant risk factor’ among stroke victims

More evidence has been published which supports that diabetes is a “significant…

Public Health England considers low carb approach for type 2 diabetes

The low carb approach is being considered by the government to be…

Top diabetes professor drafts risk assessment document for frontline COVID-19 staff

The health and wellbeing of frontline NHS staff has been prioritised among…